Other small molecules preventing tau aggregation involve thiacarbocyanines, anthraquinones, and phenylthiazolyl-hydrazides, which have been demonstrated their promising therapeutic efficacy in vitro and in vivo AD models [184,185]; yet, further investigation is required. The gene discussed is MAPT; the disease is Alzheimer disease.